Agronomics Limited (AGNMF) Research

Agronomics Limited operates as a principal investment firm, deploying capital across various financial instruments, including funds, equity, and equity-linked products. Its portfolio encompasses both publicly traded and privately held companies. A primary emphasis is placed on pioneering sectors such as alternative proteins, particularly those involved in cellular agriculture and other emerging modern food technologies. The firm is also deeply committed to the biopharma sector, actively constructing a robust portfolio of investments in both biotechnology and pharmaceutical enterprises. Beyond direct equity, Agronomics may allocate capital to collective investment schemes concentrated on the biopharma industry, as well as long-term equity anticipation securities (LEAPS) whose underlying assets are biopharma-related stocks or indices. Additionally, the firm retains the option to invest in biopharma sector debt, though such exposures are capped at 15 percent of the company's net asset value. Established on May 3, 2011, Agronomics Limited is headquartered in Ramsey, Isle of Man.

Open Agronomics Limited (AGNMF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.